ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
1 clinical trials · Condition
◉ Watch ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
| Record | Firm | Date |
|---|---|---|
| A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations (NCT01970865) | Pfizer | 2014-01-08 |
Track ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.